Foto del docente

Pier Giorgio Cojutti

Ricercatore a tempo determinato tipo b) (senior)

Dipartimento di Scienze Mediche e Chirurgiche

Settore scientifico disciplinare: BIO/14 FARMACOLOGIA

Pubblicazioni

Cojutti, Pier Giorgio; Zanon, Ezio; Pasca, Samantha; Pea, Federico, Real-Life Population Pharmacokinetics of Recombinant Factor XIII and Dosing Considerations for Preventing the Risk of Bleeding in Patients with FXIII Congenital Deficiency, «CLINICAL PHARMACOKINETICS», 2021, na, pp. 1 - 12 [articolo]

Cojutti P.G.; Rinaldi M.; Gatti M.; Tedeschi S.; Viale P.; Pea F., Usefulness of therapeutic drug monitoring in estimating the duration of dalbavancin optimal target attainment in staphylococcal osteoarticular infections: a proof-of-concept, «INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS», 2021, 58, Article number: 106445, pp. 1 - 3 [articolo]

Cojutti P.G.; Londero A.; Della Siega P.; Givone F.; Fabris M.; Biasizzo J.; Tascini C.; Pea F., Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin-6, «CLINICAL PHARMACOKINETICS», 2020, 59, pp. 1251 - 1260 [articolo]Open Access

Cojutti P.G.; Lazzarotto D.; Candoni A.; Dubbini M.V.; Zannier M.E.; Fanin R.; Pea F., Real-Time TDM-based optimization of continuous-infusion meropenem for improving treatment outcome of febrile neutropenia in oncohaematological patients: Results from a prospective, monocentric, interventional study, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2020, 75, pp. 3029 - 3037 [articolo]Open Access

Cojutti, Pier Giorgio; Maximova, Natalia; Schillani, Giulia; Hope, William; Pea, Federico, Population pharmacokinetics of continuous-infusion ceftazidime in febrile neutropenic children undergoing HSCT: implications for target attainment for empirical treatment against Pseudomonas aeruginosa, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2019, 74, pp. 1648 - 1655 [articolo]

Cojutti P.G.; Merelli M.; Bassetti M.; Pea F., Proactive therapeutic drug monitoring (TDM) may be helpful in managing long-term treatment with linezolid safely: Findings from a monocentric, prospective, open-label, interventional study, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2019, 74, pp. 3588 - 3595 [articolo]

Crass R.L.; Cojutti P.G.; Pai M.P.; Pea F., Reappraisal of linezolid dosing in renal impairment to improve safety, «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2019, 63, pp. 1 - 9 [articolo]

Cojutti P.G.; Merelli M.; Allegri L.; Damante G.; Bassetti M.; Pea F., Successful and safe long-term treatment of cerebral aspergillosis with high-dose voriconazole guided by therapeutic drug monitoring, «BRITISH JOURNAL OF CLINICAL PHARMACOLOGY», 2019, 85, pp. 266 - 269 [articolo]

Righi, Elda; Carnelutti, Alessia; Baccarani, Umberto; Sartor, Assunta; Cojutti, Piergiorgio; Bassetti, Matteo; Pea, Federico, Treatment of Candida Infections with Fluconazole in Adult Liver Transplant Recipients: Is TDM-guided Dosing Adaptation Helpful?, «TRANSPLANT INFECTIOUS DISEASE», 2019, 21, pp. e13113 - - [articolo]

Cojutti P.G.; Candoni A.; Lazzarotto D.; Rabassi N.; Fanin R.; Hope W.; Pea F., Co-administration of proton pump inhibitors and/or of steroids may be a risk factor for low trough concentrations of posaconazole delayed-released tablets in adult patients with haematological malignancies, «BRITISH JOURNAL OF CLINICAL PHARMACOLOGY», 2018, 84, pp. 2544 - 2550 [articolo]

Cojutti P.G.; Merelli M.; De Stefanis P.; Fregonese C.; Lucchese F.; Bassetti M.; Pea F., Disposition of ceftobiprole during continuous venous-venous hemodiafiltration (CVVHDF) in a single critically ill patient, «EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY», 2018, 74, pp. 1671 - 1672 [replica/breve intervento]

Cojutti P.G.; Barbarino C.; De Monte A.; Hope W.; Pea F., Higher than standard meropenem and linezolid dosages needed for appropriate treatment of an intracerebral hemorrhage patient with augmented renal clearance, «EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY», 2018, 74, pp. 1091 - 1092 [articolo]

Cojutti P.; Sartor A.; Bassetti M.; Scarparo C.; Pea F., Is meropenem MIC increase against KPC-producing Klebsiella pneumoniae correlated with increased resistance rates against other antimicrobials with Gram-negative activity?, «JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE», 2018, 14, pp. 238 - 241 [articolo]

Cojutti P.; Pai M.P.; Pea F., Population Pharmacokinetics and Dosing Considerations for the Use of Linezolid in Overweight and Obese Adult Patients, «CLINICAL PHARMACOKINETICS», 2018, 57, pp. 989 - 1000 [articolo]

Cojutti P.G.; Lugano M.; Righi E.; Della Rocca G.; Bassetti M.; Hope W.; Pea F., Population pharmacokinetics of fluconazole in liver transplantation: implications for target attainment for infections with Candida albicans and non-albicans spp, «EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY», 2018, 74, pp. 1449 - 1459 [articolo]

Ultimi avvisi

Al momento non sono presenti avvisi.